Status and phase
Conditions
Treatments
About
A Randomized, Open-Label, Single-Dose Parallel Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
16 participants in 2 patient groups
Loading...
Central trial contact
Jina Jung, PhD; Jaewoo Kim
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal